Clinical Trial Update: First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

View source ↗

Summary

An update on the CORRECT study, the first investigation of minimal residual disease detection in colorectal cancer, sponsored by Exact Sciences, currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Exact Sciences Corporation | Conditions: Colorectal Cancer | Status: ACTIVE_NOT_RECRUITING